{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:00:05Z","timestamp":1773849605517,"version":"3.50.1"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.578536","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T11:48:04Z","timestamp":1605181684000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["G Protein-Coupled Estrogen Receptor, GPER1, Offers a Novel Target for the Treatment of Digestive Diseases"],"prefix":"10.3389","volume":"11","author":[{"given":"Chelsea","family":"DeLeon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Q.-H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K.","family":"Arnatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(02)04270-3","article-title":"III, The Epidemiology of Irritable Bowel Syndrome in North America: A Systematic Review","volume":"97","author":"Saito","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5056\/jnm16138","article-title":"Sex and Gender Differences in Gastroesophageal Reflux Disease","volume":"22","author":"Kim","year":"2016","journal-title":"J Neurogastroenterol Motil"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.5056\/jnm18082","article-title":"Sex-Gender Differences in Irritable Bowel Syndrome","volume":"24","author":"Kim","year":"2018","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2012.6.2.172","article-title":"Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer","volume":"6","author":"Stinton","year":"2012","journal-title":"Gut Liver"},{"key":"B6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1742-7843.2005.pto960103.x","article-title":"Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology","volume":"96","author":"Nilsson","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/39645","article-title":"Molecular basis of agonism and antagonism in the oestrogen receptor","volume":"389","author":"Brzozowski","year":"1997","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/mend.14.10.0532","article-title":"Estrogen-Induced Activation of Erk-1 and Erk-2 Requires the G Protein-Coupled Receptor Homolog, GPR30, and Occurs via Trans-Activation of the Epidermal Growth Factor Receptor through Release of HB-EGF","volume":"14","author":"Filardo","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1210\/mend.16.1.0758","article-title":"Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis","volume":"16","author":"Filardo","year":"2002","journal-title":"Mol Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403588200","article-title":"The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells","volume":"279","author":"Maggiolini","year":"2004","journal-title":"J Biol Chem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2005.08.005","article-title":"GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release","volume":"16","author":"Filardo","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1106943","article-title":"A transmembrane intracellular estrogen receptor mediates rapid cell signaling","volume":"307","author":"Revankar","year":"2005","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/en.2012-1061","article-title":"Minireview: G Protein-Coupled Estrogen Receptor-1, GPER-1: Its Mechanism of Action and Role in Female Reproductive Cancer, Renal and Vascular Physiology","volume":"153","author":"Filardo","year":"2012","journal-title":"Endocrinology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/me.2004-0486","article-title":"Mechanisms of Estrogen Receptor Signaling: Convergence of Genomic and Nongenomic Actions on Target Genes","volume":"19","author":"Bj\u00f6rnstr\u00f6m","year":"2005","journal-title":"Mol Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1152\/jappl.2001.91.4.1860","article-title":"Invited Review: Cell localization, physiology, and nongenomic actions of estrogen receptors","volume":"91","author":"Levin","year":"2001","journal-title":"J Appl Physiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.4.1438","article-title":"Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential","volume":"80","author":"Teskarik","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(99)00190-3","article-title":"Estrogen Modulation of G-protein-coupled Receptors","volume":"10","author":"Kelly","year":"1999","journal-title":"Trends Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/clpt.2010.226","article-title":"Estrogen Receptors: Therapies Targeted to Receptor Subtypes","volume":"89","author":"Nilsson","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1064","article-title":"Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells","volume":"146","author":"Thomas","year":"2005","journal-title":"Endocrinology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2017.09.069","article-title":"Bisphenol A induces proliferative effects on both breast cancer cells and vascular endothelial cells through a shared GPER-dependent pathway in hypoxia","volume":"231","author":"Xu","year":"2017","journal-title":"Environ Pollut"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201300323","article-title":"Oleuropein and hydroxytyrosol activate GPER\/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells","volume":"58","author":"Chimento","year":"2014","journal-title":"Mol Nutr Food Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1042\/CS20180885","article-title":"Possible role of phytoestrogens in breast cancer via GPER-1\/GPR30 signaling","volume":"132","author":"Molina","year":"2018","journal-title":"Clin Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1289\/EHP2387","article-title":"Hydroxylated Polybrominated Diphenyl Ethers Exert Estrogenic Effects via Non-Genomic G Protein-Coupled Estrogen Receptor Mediated Pathways","volume":"126","author":"Cao","year":"2018","journal-title":"Environ Health Perspect"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio775","article-title":"Virtual and biomolecular screening converge on a selective agonist for GPR30","volume":"2","author":"Bologa","year":"2006","journal-title":"Nat Chem Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/minf.201200136","article-title":"G Protein-Coupled Estrogen Receptor (GPER) Agonist Dual Binding Mode Analyses Toward Understanding of Its Activation Mechanism: A Comparative Homology Modeling Approach","volume":"32","author":"Arnatt","year":"2013","journal-title":"Mol Inf"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/minf.201501024","article-title":"Homology Modeling, Validation and Dynamics of the G Protein-coupled Estrogen Receptor 1 (GPER-1)","volume":"35","author":"Bruno","year":"2016","journal-title":"Mol Inf"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2014.994102","article-title":"Deciphering the GPER\/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics, and docking simulations","volume":"33","author":"M\u00e9ndez-Luna","year":"2015","journal-title":"J Biomol Struct Dynamics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.168","article-title":"In vivo Effects of a GPR30 Antagonist","volume":"5","author":"Dennis","year":"2009","journal-title":"Nat Chem Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2011.07.002","article-title":"Identification of a GPER\/GPR30 Antagonist with Improved Estrogen Receptor Counterselectivity","volume":"127","author":"Dennis","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.8b00212","article-title":"A Series of Indole-Thiazole Derivatives Act as GPER Agonists and Inhibit Breast Cancer Cell Growth","volume":"9","author":"O\u2019Dea","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010716-104651","article-title":"GPER (GPR30): A Nongenomic Receptor (GPCR) for Steroid Hormones with Implications for Cardiovascular Disease and Cancer","volume":"57","author":"Feldman","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2174\/156800912800673284","article-title":"Two novel GPER agonists induce gene expression changes and growth effects in cancer cells","volume":"12","author":"Lappano","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1039\/C5MD00455A","article-title":"Integrating multicomponent flow synthesis and computational approaches for the generation of a tetrahydroquinoline compound based library","volume":"7","author":"Cerra","year":"2016","journal-title":"Med Chem Comm 7"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.RA119000592","article-title":"Novel GPER Antagonist Protects Against the Formation of Estrogen-Induced Cholesterol Gallstones in Female Mice","volume":"61","author":"DeLeon","year":"2020","journal-title":"J Lipid Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.15.3","article-title":"Identification of two benzopyrroloxazines acting as selective GPER antagonists in breast cancer cells and cancer-associated fibroblasts","volume":"7","author":"Maggiolini","year":"2015","journal-title":"Future Med Chem"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1242\/dmm.021071","article-title":"A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models","volume":"8","author":"Lappano","year":"2015","journal-title":"Dis Models Mech"},{"key":"B37","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/bcr3096","article-title":"MIBE acts as antagonist ligand of both estrogen receptor \u03b1 and GPER in breast cancer cells","volume":"14","author":"Lappano","year":"2012","journal-title":"Breast Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160114","article-title":"GPER-novel membrane oestrogen receptor","volume":"130","author":"Zimmerman","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.224071","article-title":"Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway","volume":"286","author":"Cheng","year":"2011","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2015.07.016","article-title":"The G-protein coupled estrogen receptor, GPER: The inside and inside-out story","author":"Gaudet","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"B41","volume-title":"Gallstones: Recent advances in epidemiology, pathogenesis, diagnosis and management","author":"Wang","year":"2017"},{"key":"B42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/B978-0-12-801238-3.65861-0","article-title":"Bile formation and pathophysiology of gallstones","volume-title":"Encyclopedia of Gastroenterology","author":"Wang","year":"2020"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197601222940403","article-title":"Effects of oral contraceptives on the gallbladder bile of normal women","volume":"294","author":"Bennion","year":"1976","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.19.1466","article-title":"A prospective study of symptomatic gallstones in women: relation with oral contraceptives and other risk factors","volume":"84","author":"Grodstein","year":"1994","journal-title":"Obstetr Gynecol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.7326\/0003-4819-128-9-199805010-00001","article-title":"Postmenopausal hormone use and cholecystectomy in a large prospective study","volume":"83","author":"Grodstein","year":"1994","journal-title":"Obstetr Gynecol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/00042192-200007030-00006","article-title":"Estrogen replacement therapy and gallbladder disease in postmenopausal women","volume":"7","author":"Uhler","year":"2000","journal-title":"Menopause"},{"key":"B47","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7326\/0003-4819-135-7-200110020-00008","article-title":"Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen\/progestin Replacement Study","volume":"135","author":"Simon","year":"2001","journal-title":"Ann Internal Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000113897","article-title":"Hormone replacement therapy and symptomatic gallstones - a prospective population study in the EPIC-Norfolk cohort","volume":"77","author":"Hart","year":"2008","journal-title":"Digestion"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114977","article-title":"Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism","volume":"87","author":"Everson","year":"1991","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2105\/AJPH.78.10.1365","article-title":"Estrogen use and gallstone disease","volume":"78","author":"Petitti","year":"1988","journal-title":"Am J Public Health"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.5.1.117","article-title":"Is there a link between oestrogen therapy and gallbladder disease","volume":"5","author":"Dhiman","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.3.330","article-title":"Effect of estrogen therapy on gallbladder disease","volume":"293","author":"Cirillo","year":"2005","journal-title":"J Am Med Assoc"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"J Am Med Assoc"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91192-7","article-title":"Hepatic cholesterol metabolism in estrogen-treated men","volume":"103","author":"Angelin","year":"1992","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114240","article-title":"Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma","volume":"84","author":"Henriksson","year":"1989","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90309-O","article-title":"Estrogen-induced gallstones in males","volume":"98","author":"Sweeting","year":"1990","journal-title":"Gastroenterology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2009.06.006","article-title":"New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation","volume":"1791","author":"Wang","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.059","article-title":"Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones","volume":"127","author":"Wang","year":"2004","journal-title":"Gastroenterology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-002-6468-4","article-title":"Tamoxifen and gallstone formation in postmenopausal breast cancer patients: retrospective cohort study","volume":"27","author":"Akin","year":"2003","journal-title":"World J Surg"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M500454-JLR200","article-title":"Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice","volume":"47","author":"Wang","year":"2006","journal-title":"J Lipid Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2015.07.020","article-title":"The deletion of the estrogen receptor alpha gene reduces susceptibility to estrogen-induced cholesterol cholelithiasis in female mice","volume":"1852","author":"de Bari","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00335-004-2446-5","article-title":"Single and interacting QTLs for cholesterol gallstones revealed in an intercross between mouse strains NZB and SM","volume":"16","author":"Lyons","year":"2005","journal-title":"Mamm Genome"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.10.024","article-title":"Cholesterol gallstone susceptibility loci: a mouse map, candidate gene evaluation, and guide to human LITH genes","volume":"131","author":"Lyons","year":"2006","journal-title":"Gastroenterology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.gtc.2010.02.007","article-title":"Lith genes and genetic analysis of cholesterol gallstone formation","volume":"39","author":"Wang","year":"2010","journal-title":"Gastroenterol Clinics North Am"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1276645","article-title":"Dissecting the genetic heterogeneity of gallbladder stone formation","volume":"31","author":"Krawczyk","year":"2011","journal-title":"Semin Liver Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MOG.0000000000000417","article-title":"Mouse models of gallstone disease","volume":"34","author":"Wang","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31212","article-title":"Activation of a novel estrogen receptor GPR30 enhances cholesterol cholelithogenesis in female mice","author":"Wang","year":"2020","journal-title":"Hepatology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/MOG.0000000000000423","article-title":"An update on the pathogenesis of cholesterol gallstone disease","volume":"34","author":"Di Ciaula","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M059121","article-title":"Estrogen induces two distinct cholesterol crystallization pathways by activating ERalpha and GPR30 in female mice","volume":"56","author":"de Bari","year":"2015","journal-title":"J Lipid Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)30975-5","article-title":"Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment","volume":"13","author":"de Bari","year":"2014","journal-title":"Ann Hepatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22204","article-title":"Coordinate regulation of gallbladder motor function in the gut-liver axis","volume":"47","author":"Portincasa","year":"2008","journal-title":"Hepatology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20534","article-title":"Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy","volume":"41","author":"Ko","year":"2005","journal-title":"Hepatology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00730.x","article-title":"Risk factors for gallstone-related hospitalization during pregnancy and the postpartum","volume":"101","author":"Ko","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-4-199902160-00016","article-title":"Biliary sludge","volume":"130","author":"Ko","year":"1999","journal-title":"Ann Internal Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.RA119000592","article-title":"A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice","volume":"61","author":"DeLeon","year":"2020","journal-title":"J Lipid Res"},{"key":"B77","article-title":"Gallstone Disease","volume-title":"Sleisenger and Fordtrans Gastrointestinal and Liver Disease","author":"Wang","year":"2020"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1007\/s12035-016-0045-6","article-title":"L-Type Calcium Channels Modulation by Estradiol","volume":"54","author":"Vega-Vela","year":"2017","journal-title":"Mol Neurobiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.steroids.2016.02.018","article-title":"Rapid estrogen actions on ion channels: A survey in search for mechanisms","volume":"111","author":"Kow","year":"2016","journal-title":"Steroids"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-5064-8","article-title":"G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifen","volume":"174","author":"Ignatov","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"B81","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10549-009-0624-6","article-title":"Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells","volume":"123","author":"Ignatov","year":"2010","journal-title":"Breast Cancer Res Treat"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.578536\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T11:48:07Z","timestamp":1605181687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.578536\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":81,"alternative-id":["10.3389\/fendo.2020.578536"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.578536","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"article-number":"578536"}}